Related Experiment Video
Updated: Dec 31, 2025

11:17
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
12.4K
Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder: The first-reported Latin-American
Claudio Escanilla1, Piedad Marcela Guavita Falla2, Carolina Cevallos3
1Instituto Chileno de Cabeza y Cuello Santiago Chile.
Clinical Case Reports
|January 2, 2020
Abstract:
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder is a provisional entity according to the last WHO-EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potential low-cost and effective alternative for this disorder.
